Clinical Researcher—May 2021 (Volume 35, Issue 4) OVER THE TRANSOM Gary W. Cramer One thing you’ll hear over and over when seasoned clinical research professionals start talking about how […]
While he’s a big fan of decentralized clinical trials (DCTs), THREAD CEO John Reites expects to see some “contraction” in their usage as the COVID-19 pandemic subsides. “Many people are […]
Despite the fact that certain racial and ethnic minorities get pancreatic cancer more often, are diagnosed at a younger age, and die sooner, clinical trials fail to include representative proportions […]
The International Coalition of Medicines Regulatory Authorities (ICMRA), a voluntary coalition of regulatory leaders that provides strategic directions for enhanced cooperation, improved communication, and effective global crisis response mechanisms, and […]
A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits […]